Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

7.60USD
22 Jun 2017
Change (% chg)

$0.02 (+0.26%)
Prev Close
$7.58
Open
$7.59
Day's High
$7.79
Day's Low
$7.46
Volume
328,051
Avg. Vol
424,384
52-wk High
$11.71
52-wk Low
$4.01

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.20 December 23 Jun 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.20 1.20 1.20 1.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 3 3.87 4.70 3.40 5.70
Quarter Ending Sep-17 3 4.83 6.40 3.40 12.40
Year Ending Dec-17 3 20.57 32.20 13.50 46.03
Year Ending Dec-18 3 82.35 140.25 32.30 103.10
Earnings (per share)
Quarter Ending Jun-17 3 -0.20 -0.19 -0.20 -0.14
Quarter Ending Sep-17 3 -0.20 -0.19 -0.22 -0.08
Year Ending Dec-17 3 -0.79 -0.68 -0.87 -0.33
Year Ending Dec-18 4 -0.02 0.63 -0.59 0.31

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-17 4.49 2.35 2.15 47.75
Quarter Ending Dec-16 4.44 4.65 0.21 4.75
Quarter Ending Sep-16 52.90 53.85 0.95 1.80
Quarter Ending Jun-16 6.32 8.48 2.15 34.01
Quarter Ending Mar-16 3.27 2.45 0.82 25.07
Earnings (per share)
Quarter Ending Mar-17 -0.19 -0.23 0.05 -24.32
Quarter Ending Dec-16 -0.20 -0.10 0.10 -48.98
Quarter Ending Sep-16 0.55 0.52 0.03 4.88
Quarter Ending Jun-16 -0.13 -0.08 0.05 -38.46
Quarter Ending Mar-16 -0.12 -0.18 0.06 -44.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 3.87 3.87 3.87 5.20 5.70
Quarter Ending Sep-17 4.83 4.83 4.83 9.21 12.40
Year Ending Dec-17 20.57 20.57 20.57 32.56 46.03
Year Ending Dec-18 82.35 82.35 95.27 97.67 103.10
Earnings (per share)
Quarter Ending Jun-17 -0.20 -0.20 -0.20 -0.17 -0.14
Quarter Ending Sep-17 -0.20 -0.20 -0.20 -0.13 -0.08
Year Ending Dec-17 -0.79 -0.79 -0.79 -0.54 -0.33
Year Ending Dec-18 -0.02 -0.02 0.10 0.16 0.31

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 0 0 0 0
Quarter Ending Sep-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Jun-17 0 0 0 0
Quarter Ending Sep-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0

More From Around the Web